Impact BioMedical Inc.

AMEX: IBO · Real-Time Price · USD
0.55
-0.02 (-3.00%)
At close: Aug 15, 2025, 2:36 PM

Impact BioMedical Income Statement

Financials in CAD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.33M 1.03M 1.07M n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
2.33M 1.03M 1.07M n/a
Operating Income
551.66K -28.03K 497.15K -3.83M
Interest Income
5.69K n/a n/a 31.82K
Pretax Income
-2.05M -2.39M -10.5M -3.87M
Net Income
-2.05M -2.39M -10.5M -3.87M
Selling & General & Admin
1.02M 1.72M 4.57M 3.73M
Research & Development
91.77K 9.21K 409.31K 63.2K
Other Expenses
670.05K -668.6K -127.55K n/a
Operating Expenses
1.78M 1.06M 5.82M 3.86M
Interest Expense
168.95K 118.13K 67.74K 15.01K
Selling & Marketing Expenses
n/a n/a n/a 200.98K
Cost & Expenses
1.78M 1.06M 5.82M 3.86M
Income Tax Expense
n/a n/a -59.8K 15.01K
Shares Outstanding (Basic)
232.5M 191.3M 185.64M 125.19M
Shares Outstanding (Diluted)
232.5M 191.3M 185.64M 125.19M
EPS (Basic)
-0.01 -0.01 -0.06 -0.03
EPS (Diluted)
-0.01 -0.01 -0.06 -0.03
EBITDA
-1.54M -1.98M -4.61M -3.76M
EBIT
-1.88M -2.27M n/a -3.83M
Depreciation & Amortization
343.46K 296.05K 266.4K 69.86K